Peripheral arterial disease in patients with Behçet’s disease

[1]  K. Park,et al.  Peripheral arterial involvement in Behcet’s disease: an analysis of the results from a Korean referral center , 2013, Rheumatology International.

[2]  I. Baumgartner,et al.  Behçet's disease: Successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis , 2012, Arthritis care & research.

[3]  M. Bértolo,et al.  Behçet’s disease in Brazilian patients: demographic and clinical features , 2012, Rheumatology International.

[4]  A. Pathare,et al.  Pattern and outcome of vascular involvement of Omani patients with Behcet’s disease , 2011, Rheumatology International.

[5]  C. Cerquaglia,et al.  Efficacy of etanercept in the treatment of a patient with Behçet’s disease , 2008, Clinical Rheumatology.

[6]  D. Mikhailidis,et al.  Short-term Lipid-Lowering Treatment with Atorvastatin Improves Renal Function But Not Renal Blood Flow Indices in Patients with Peripheral Arterial Disease , 2006, Angiology.

[7]  D. Mikhailidis,et al.  Risk Modification in Patients with Peripheral Arterial Disease: A Retrospective Survey , 2005, Angiology.

[8]  A. Doğan,et al.  Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet’s disease , 2005, Rheumatology International.

[9]  E. Ayaşlıoğlu,et al.  Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease , 2003, Rheumatology International.

[10]  K. Sağlam,et al.  Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease , 2001, Rheumatology International.

[11]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .